Literature DB >> 20878132

microRNA-143, down-regulated in osteosarcoma, promotes apoptosis and suppresses tumorigenicity by targeting Bcl-2.

Hao Zhang1, Xiaobing Cai, Yang Wang, Hao Tang, Daki Tong, Fang Ji.   

Abstract

Deregulated microRNAs and their roles in tumorigenesis are still largely unknown. Here, we focused on the roles of miR-143 in osteosarcoma, as previous reports have suggested its importance in some other types of cancer. We found that miR-143 was down-regulated in osteosarcoma cell lines and primary tumor samples, and the restoration of miR-143 reduced cell viability, promoted cell apoptosis and suppressed tumorigenicity. Additionally, Bcl-2, an important antiapoptotic molecule, was identified to be a novel direct target of miR-143, and the proapoptotic function of miR-143 is further suggested to be mainly through the targeting of Bcl-2 expression. Collectively, our data identify the important roles of miR-143 in osteosarcoma pathogenesis and indicate its potential application in cancer therapy.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20878132     DOI: 10.3892/or_00000994

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  77 in total

1.  MicroRNA cloning and sequencing in osteosarcoma cell lines: differential role of miR-93.

Authors:  Luisa Montanini; Lisa Lasagna; Valeria Barili; Søren Peter Jonstrup; Alba Murgia; Laura Pazzaglia; Amalia Conti; Chiara Novello; Jørgen Kjems; Roberto Perris; Maria Serena Benassi
Journal:  Cell Oncol (Dordr)       Date:  2011-09-30       Impact factor: 6.730

Review 2.  Missing link between microRNA and prostate cancer.

Authors:  Balraj Singh Gill; Jimi Marin Alex; Sanjeev Kumar
Journal:  Tumour Biol       Date:  2016-01-28

Review 3.  MicroRNA and AU-rich element regulation of prostaglandin synthesis.

Authors:  Ashleigh E Moore; Lisa E Young; Dan A Dixon
Journal:  Cancer Metastasis Rev       Date:  2011-12       Impact factor: 9.264

4.  MiR-182 is up-regulated and targeting Cebpa in hepatocellular carcinoma.

Authors:  Chenggang Wang; Ren Ren; Haolin Hu; Changjun Tan; Miao Han; Xiaolin Wang; Yun Zheng
Journal:  Chin J Cancer Res       Date:  2014-02       Impact factor: 5.087

Review 5.  microRNAs in cancer cell response to ionizing radiation.

Authors:  Jennifer R Czochor; Peter M Glazer
Journal:  Antioxid Redox Signal       Date:  2014-02-04       Impact factor: 8.401

6.  MicroRNA-1271 inhibits cellular proliferation of hepatocellular carcinoma.

Authors:  Andong Qin; Jiehua Zhu; Xingxiang Liu; Dongxiao Zeng; Maolin Gu; Chun Lv
Journal:  Oncol Lett       Date:  2017-09-25       Impact factor: 2.967

Review 7.  Restoring TGFβ1 pathway-related microRNAs: possible impact in metastatic prostate cancer development.

Authors:  Juliana Inês Santos; Ana Luísa Teixeira; Francisca Dias; Mónica Gomes; Augusto Nogueira; Joana Assis; Rui Medeiros
Journal:  Tumour Biol       Date:  2014-04-25

Review 8.  miRNA signatures in childhood sarcomas and their clinical implications.

Authors:  G M Viera; K B Salomao; G R de Sousa; M Baroni; L E A Delsin; J A Pezuk; M S Brassesco
Journal:  Clin Transl Oncol       Date:  2019-04-04       Impact factor: 3.405

9.  Downregulation of miR-136 promotes the progression of osteosarcoma and is associated with the prognosis of patients with osteosarcoma.

Authors:  Yanchen Chu; Xiaoli Hu; Guangfeng Wang; Zhijie Wang; Yanjin Wang
Journal:  Oncol Lett       Date:  2019-04-01       Impact factor: 2.967

10.  Perturbation of 14q32 miRNAs-cMYC gene network in osteosarcoma.

Authors:  Venugopal Thayanithy; Aaron L Sarver; Reena V Kartha; Lihua Li; Andrea Y Angstadt; Matthew Breen; Clifford J Steer; Jaime F Modiano; Subbaya Subramanian
Journal:  Bone       Date:  2011-10-18       Impact factor: 4.398

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.